Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (21-30 of 487) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?Vivek Subbiah, Boyi Gan
Trends in Cancer|June 26, 2018
Mining Public Databases for Precision OncologyJason Roszik, Vivek Subbiah
European Journal of Internal Medicine|February 25, 2016
Headache in a patient with renal cell carcinomaVivek Subbiah, Abhishek Maiti
Cell Cycle (Georgetown, Tex.)|March 21, 2017
Towards precision oncology in RET-aberrant cancersVivek Subbiah, Jason Roszik
JCO Oncology Practice|June 11, 2025
Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare CancersVivek Subbiah, Razelle Kurzrock
Cancer|October 30, 2022
Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapyAakash Desai, Vivek Subbiah
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?Aakash Desai, Vivek Subbiah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: <i>Genomics Is the Diagnosis</i>Vivek Subbiah, Razelle Kurzrock
Cancer Cell|August 30, 2024
Precision oncology across the ages: Impact on children, adolescents, and young adultsVivek Subbiah, Razelle Kurzrock
Nature Reviews. Drug Discovery|May 29, 2026
Closing the paediatric gap in cancer drug development: a call to industryVivek Subbiah, Branko Cuglievan
Pageof 49

Showing results (21-30 of 487) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?Vivek Subbiah, Boyi Gan
Trends in Cancer|June 26, 2018
Mining Public Databases for Precision OncologyJason Roszik, Vivek Subbiah
European Journal of Internal Medicine|February 25, 2016
Headache in a patient with renal cell carcinomaVivek Subbiah, Abhishek Maiti
Cell Cycle (Georgetown, Tex.)|March 21, 2017
Towards precision oncology in RET-aberrant cancersVivek Subbiah, Jason Roszik
JCO Oncology Practice|June 11, 2025
Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare CancersVivek Subbiah, Razelle Kurzrock
Cancer|October 30, 2022
Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapyAakash Desai, Vivek Subbiah
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?Aakash Desai, Vivek Subbiah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: <i>Genomics Is the Diagnosis</i>Vivek Subbiah, Razelle Kurzrock
Cancer Cell|August 30, 2024
Precision oncology across the ages: Impact on children, adolescents, and young adultsVivek Subbiah, Razelle Kurzrock
Nature Reviews. Drug Discovery|May 29, 2026
Closing the paediatric gap in cancer drug development: a call to industryVivek Subbiah, Branko Cuglievan
Pageof 49